NASDAQ:IXHL Incannex Healthcare Q1 2027 Earnings Date & Estimates $2.64 +0.04 (+1.54%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$2.63 -0.01 (-0.34%) As of 10/23/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Incannex Healthcare is estimated to report Q1 2027 earnings on Friday, November 13, 2026. The conference call is scheduled for 9:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ1 2027Announcement DateNovember 13, 2026Conference Call9:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Incannex Healthcare in Q1 2027Incannex Healthcare is expected to post earnings of -$0.66 per share on revenue of $10.00 million. In the same quarter a year earlier Incannex Healthcare reported -$0.60 per share on revenue of $0.05 million. Incannex Healthcare last reported on September 25, 2026, posting -$0.14 per share and missing the $0.13 consensus estimate. Incannex Healthcare has beaten the consensus EPS estimate in 2 of its last 5 quarters.Consensus EstimatesConsensus EPS-$0.66Expected Revenue$10.00 millionPrior-Year EPS-$0.60Prior-Year Revenue$0.05 millionExpected Revenue Growth+20,733.3%Recent Track RecordLast ReportedQ4 2026Last Quarter EPS-$0.14 (Missed by -$0.27)EPS Beat Rate2 of last 5 quartersPrepare for the Q1 2027 CallEarnings HistoryCompany ProfileQ4 2026 Earnings ReportQ2 2026 Earnings ReportQ1 2026 Earnings Report Incannex Healthcare Q1 2027 Earnings FAQ When does Incannex Healthcare report Q1 2027 earnings? Incannex Healthcare (NASDAQ:IXHL) is estimated to report Q1 2027 earnings on Friday, November 13, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Incannex Healthcare's Q1 2027 earnings call? Incannex Healthcare's Q1 2027 earnings conference call is scheduled for Friday, November 13, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Incannex Healthcare? Analysts expect Incannex Healthcare to post earnings of -$0.66 per share for Q1 2027. How much revenue is Incannex Healthcare expected to report? The consensus revenue estimate for Incannex Healthcare is $10.00 million for Q1 2027. Incannex Healthcare Earnings HeadlinesHead-To-Head Review: Incannex Healthcare (NASDAQ:IXHL) vs. Can-Fite BioPharma (NYSE:CANF)October 16, 2026 | americanbankingnews.comIncannex Healthcare Inc. Reports Earnings Results for the Full Year Ended June 30, 2026September 25, 2026 | marketscreener.comMBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.October 25 at 1:00 AM | Decentralized Masters (Ad)Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital PositionSeptember 9, 2026 | globenewswire.comIncannex Healthcare Doses First Patient in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep ApneaAugust 25, 2026 | quiverquant.comQIncannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42XAugust 25, 2026 | globenewswire.comSee More Incannex Healthcare Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Incannex Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Incannex Healthcare and other key companies, straight to your email. Email Address About Incannex HealthcareIncannex Healthcare (NASDAQ:IXHL) Limited (NASDAQ: IXHL) is an Australia-based clinical-stage pharmaceutical company developing cannabinoid- and psychedelic-assisted therapies for conditions with significant unmet medical needs. The company’s research programs are focused on areas including sleep disorders, pain, inflammation, mental health and traumatic brain injury. Incannex’s lead programs have included IHL-42X, an investigational combination therapy being developed for obstructive sleep apnea, and IHL-675A, a cannabinoid-based therapy studied for inflammatory conditions. The company has also pursued psychedelic-assisted treatment approaches for conditions such as post-traumatic stress disorder and traumatic brain injury. These products remain investigational and are subject to clinical testing and regulatory approval. Founded in Australia, Incannex conducts development activities in Australia and the United States and has sought to advance its therapies through clinical trials and regulatory pathways in both markets. The company is led by Chief Executive Officer and Managing Director Joel Latham.View Incannex Healthcare ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineNewmont’s Record Quarter Shows Why Gold’s Floor Is the Real StoryLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestCan Planet Fitness Get Its Growth Back in Shape?Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
